biomarker detection
In Brief This Week: CareDx; Centogene; Exagen; VolitionRx; More
News items for the week of March 10, 2025
GAP Foundation Launches Second Study on Alzheimer's Blood Biomarkers
In Bio-Hermes-002, the nonprofit is hoping to evaluate the ability of individual or a combination of biomarkers to predict amyloid and tau aggregation.
The biomarker p-tau 217 best correlated with other established signs of Alzheimer's disease in a head-to-head study evaluating six blood-based assays.
Davos Alzheimer's Collaborative Creates Initiative to Improve Alzheimer's Diagnosis
Under the program, blood biomarkers and confirmatory diagnostic testing will be used to increase diagnosis of Alzheimer’s disease and related dementias.
Roche Licenses ALZpath's pTau217 Antibody for Use in Alzheimer's Blood Tests
pTau217, a blood-based biomarker highly predictive of beta-amyloid positivity, may eventually be used to identify patients eligible for new Alzheimer's drugs.
Feb 21, 2024
Tagomics Raises £6.7M in Private Funding Round
Mar 30, 2023
Aug 15, 2022